Large Cell Lymphoma Pilot Study III

Completed · Not applicable

Conditions studied: Lymphoma, Large Cell, Lymphoma, Non-Hodgkin

In brief

The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes an intensification phase with hematopoietic stem cell support for children with large cell lymphoma

Key facts

Study ID

NCT00187070

Run by

St. Jude Children's Research Hospital

People needed

8

Starts

1997-12-01

Expected to finish

2001-07-01

Last updated by the study team

2008-05-07

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient must be previously untreated, except for steroids or emergency radiation therapy.
• Patient must be less than or equal to 18 years of age.
• Patient must have a histologic diagnosis of large cell Non-Hodgkin lymphoma.
• The immunophenotype of tumor cells must be either T-cell or non-B-cell, non-T-cell.

You may not qualify if…

• Participants with B-cell immunophenotype NHL.

Where it is running

• St. Jude Children's Reaearch Hospital — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.